Viewing Study NCT02646735


Ignite Creation Date: 2025-12-24 @ 10:06 PM
Ignite Modification Date: 2026-01-02 @ 1:25 PM
Study NCT ID: NCT02646735
Status: UNKNOWN
Last Update Posted: 2017-01-02
First Post: 2016-01-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Fulvestrant 500mg With Exemestane Endocrine Therapy for Postmenopausal Advanced Breast Cancer Patients
Sponsor: Chinese Academy of Medical Sciences
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module